BioSpace News Archive

BioMidwest

Spectrum Pharmaceuticals Initiates Same Day Dosing Clinical Trial for ROLONTIS® (eflapegrastim)

Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, announced dosing of the first patient in a clinical trial to evaluate the administration of ROLONTIS on the same day as chemotherapy.

April 30, 2020
·
5 min read
Business

AVEO Oncology Reports First Quarter 2020 Financial Results and Provides Business Update

AVEO Oncology reported financial results for the first quarter ended March 31, 2020 and provided a business update.

April 30, 2020
·
15 min read
Deals

IMV Announces Proposed $22.3 Million Private Placement

IMV Inc. announced its intention to complete a private placement of 7,797,203 units of the Company at the market price of Cdn$2.86 per Unit based on the volume-weighted average price calculated over the 5 days ending Friday, April 24, 2020.

April 30, 2020
·
4 min read
Business

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2020 Earnings and Company Updates

Intellia Therapeutics, Inc., a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present its first quarter 2020 financial results and operational highlights in a conference call on May 7, 2020 at 8 a.m. ET..

April 30, 2020
·
1 min read
BioMidwest

Encompass Health to present at UBS Virtual Global Healthcare Conference

Encompass Health Corp. announced it will participate in the UBS Virtual Global Healthcare Conference being held May 18‑20, 2020.

April 30, 2020
·
1 min read
Business

Baxter Reports First-Quarter 2020 Results

Baxter International Inc., a leading global medical products company, reported results for the first quarter of 2020.

April 30, 2020
·
22 min read
Drug Development

InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755

InMed Pharmaceuticals Inc. announced it has received regulatory and ethics board approval of its Clinical Trial Application to conduct its second Phase 1 trial with INM-755.

April 30, 2020
·
5 min read
Hepatorenal Syndrome Treatment Market: Exponential Growth in Therapeutics Boosts Growth of Market

Transparency Market Research has published a new report on the hepatorenal syndrome treatment market for the forecast period of 2019–2027.

April 30, 2020
·
4 min read
Companion Animal Diagnostics Market : In-house Disease Testing of Pets to Gain Popularity

Transparency Market Research has published a new report on the companion animal diagnostics market for the forecast period of 2019–2027.

April 30, 2020
·
5 min read
Policy

Medivir Receives Positive Opinion on Orphan Medicinal Drug Designation by the European Medicines Agency for MIV-818

Medivir AB announced that it has received positive opinion from the Committee for Orphan Medicinal Products on orphan medicinal product designation in the EU for MIV-818 for the treatment of patients with hepatocellular carcinoma, the most common type of primary liver cancer.

April 30, 2020
·
2 min read